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Professor Frank Pasquale – Challenging 
Conventional Wisdom and Changing the Narrative 
on the Future of the U.S. Health Care System
When Professor Frank Pasquale 
joined the Maryland Carey 
Law faculty in 2013, the U.S. 
was on the verge of launching 
major data-sharing initiatives to 
implement the Affordable Care 
Act.  At that time, in a previous 
edition of this newsletter, Pasquale 
warned that new and rapidly 
changing technologies held 
both promise and peril for the 
health care industry.  Now, three 
years later, the Affordable Care 
Act has transformed all sectors 
of the health care industry and 
Pasquale’s message is still the 
same, if slightly more urgent, and 
decision makers are listening.  In 
July 2016, at the White House-
sponsored Artificial Intelligence 
Now conference which convened leading thinkers on robotics law and 
policy, Pasquale gave a talk on automation in health care.  In the talk, he 
warned about problems likely to be caused if robots prematurely replace the 
work of humans. A recording of Pasquale’s talk is available at http://ainow.
staging.mysociety.org/schedule/conference/presentation/complementary-
vs-substitutive-automation-healthcar. This high profile talk capped a year of 
speaking and writing on cutting edge topics in health information law and 
policy, including talks at the Food and Drug Administration, the European 
Medicines Agency, and the London School of Economics (with the head of 
NHS Digital, Britain’s leading health data authority).  
On April 6-7, 2017, Pasquale will be hosting a roundtable at Maryland 
Carey Law that focuses on automation in health care called “The Future 
of Automation, Clinical Decision Support, and Robotics in Health Law & 
Policy.”  The by-invitation roundtable will bring together thought leaders 
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Symposium Topics
•	 How do stakeholders assure data quality given increasing 
demands on the time of providers?
•	 What are best practices for assuring privacy when innovations 
like cloud robotics could lead to constant real-time monitoring 
of patients?
•	 How should learning health care systems and predictive 
analytics programs be audited for quality and reliability?
•	 Are “care robots” a practical solution to the aging of the baby 
boomers, or an oxymoron?
•	 Will certain forms of sophisticated data analysis become the 
“standard of care?” Should they?
•	 Do current or future payment models bias the development of 
technology in certain directions? 
•	 What is the potential for data-driven health care to curb or 
exacerbate health disparities?
•	 Can black box medicine, such as machine learning that cannot 
be reverse engineered or otherwise understood by humans, 
offer valid clinical decision support? Should versions of it be 
made available to consumers as apps?
in health technology and law to consider regulatory issues raised by 
the rise of population health management, predictive analytics, and 
robotics. Each field raises fundamentally new issues with respect to 
data management and privacy, liability, and reimbursement. 
The roundtable will include participant experts in the fields of 
electronic health records, clinical decision support, and robotics.  
To kick off the roundtable, renowned expert in health information 
technology, Nicolas P. Terry, will serve as the law school’s Rome 
Lecturer on Thursday, April 6 at 5pm in the Ceremonial Moot Court 
Room.  Professor Terry is the Hall Render Professor of Law and 
Executive Director of the William S. and Christine S. Hall Center for 
Law and Health at Indiana University’s Robert H. McKinney School of 
Law.  The lecture is open to the public.
Symposium 
The Future of Automation, Clinical 
Decision Support, and Robotics in  
Health Law & Policy
April 7, 2017, Maryland Carey
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The roundtable will be an opportunity for Pasquale 
to engage stakeholders in robust discussions on the 
topics that he has been writing and lecturing about 
in the last few years—and to sound the warning 
bell regarding premature automation of critical 
tasks. Machines are edging out the human worker 
with many potential consequences, including mass 
unemployment. But there are bright spots as machines 
evolve. Pasquale suggests that robotics or software 
are not just beneficial, but potentially lifesaving, 
replacing humans “for dangerous or degrading work.” 
Technological innovations can help collect trash or 
remediate sites contaminated by nuclear radiation, 
for example. But automating health industry jobs 
such as providing care and counseling patients and 
their families raises different questions entirely. For 
example, one company has already developed a baby 
seal robot to comfort patients in hospitals and nursing 
homes.
medicine.  Pasquale believes that medicine is moving 
forward with automation on the assumption that much 
of what doctors do is algorithmic and that much of the 
work of health care is matching a set of symptoms to 
an optimal cure or treatment—a pattern recognition 
problem ideally suited to machine learning. Although 
recognizing the promise of automation to improve 
health outcomes, particularly in the developing 
world, Pasquale is urgently asking policy makers to 
understand that medicine’s new wave of big data and 
predictive analytics could mislead patients, erode 
physicians’ skills, and subject the most vulnerable 
patients to “cookbook medicine” that fails to respect 
their values or interests, to the extent it replaces (rather 
than complements) the work of qualified professionals.
Pasquale believes that, at present, software doesn’t 
have the “spontaneity, creativity, flexibility, and 
perceptiveness that are the hallmarks of skilled 
doctors and nurses.” While some areas of medicine, 
such as monitoring drug interactions are appropriate 
for automation, some areas clearly are not. And even 
automated clinical decision support for drug-drug 
interactions has created a problem of “alert fatigue,” 
which technologists and policymakers have yet to 
solve. When it comes to end of life care, Pasquale 
notes, easing the anxiety and suffering of others 
requires a human touch. The idea of mapping out 
every possibility in advance, and mechanizing the 
termination of treatment, should alarm anyone with 
personal or professional experience in an intensive 
care unit, nursing home, or hospice. The stakes are 
so high, the concept of quality of life so personal and 
ineffable, the decision-making so properly shared 
among family and providers, that algorithms should 
only aid around the edges. Pasquale will be presenting 
his work at a conference at Princeton this December 
organized by Paul Starr (author of The Transformation 
of American Health Care).
Cautiously developing technology to improve the 
field of medicine while preserving the humanity of 
providing care will certainly cost money and time, 
according to Pasquale. “As professionals grapple 
with new forms of advice and support based on 
software and robots, they deserve laws and policies 
designed to democratize opportunities for productivity 
and autonomy,” he says.  As implementation of 
the Affordable Care Act moves forward, Pasquale 
is clear that the cost-savings anticipated under the 
Act and future legislation must not create such an 
Paro the Robo-Seal, a therapeutic robot baby seal to calm 
patients in hospitals and nursing homes
The current push for automation is a call-to-action 
for regulators, according to Pasquale: “Retarding 
automation that controls, stigmatizes and cheats 
innocent people is a vital role for 21st century 
regulators.” Using automation to slash prices 
should not be the primary goal of this new era of 
technology, Pasquale cautions, because it is too 
easy for automation’s proponents to change and 
radically simplify tasks and then declare their work 
done. Maintaining and improving quality are just as 
important as cost cutting. Pasquale is under contract 
with Harvard University Press to publish a book on 
this topic called “Humane Automation: The Future 
Logic of Professionalism” in 2018.
Pasquale’s book will discuss the impact of 
automation on a number of professions, including 
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administrative and technological burden for physicians 
that current and future providers leave the field.
The risks of cost-cutting in health care was 
addressed in Pasquale’s 2015 article, “The Hidden 
Costs of Health Care Cost-Cutting: Toward a 
Postneoliberal Health-Reform Agenda” in Duke Law 
School’s Law and Contemporary Problems (77 Law 
& Contemporary Problems 171-193 (2015)).  In the 
article he states that beneath the superficial consensus 
that “health care is too expensive,” there are raging 
debates on strategies of cost containment with some 
favoring supply-side limits by reducing the quantity 
or price of providers and others focusing on the 
demand side and reducing expenditures on health care. 
Others support the “quality movement” and believe 
costs can be reduced by shifting spending to effective 
interventions.  But Pasquale thinks policymakers need 
to take an urgent step back and ask the basic question 
—how much should our society spend on health 
care? The article provides a rationale for why this 
question must be answered before policymakers point 
to high health care spending in itself as a rationale 
for reducing the purchasing power of patients, 
reducing compensation of physicians, nurses, and 
other providers, or deterring investment in hospitals, 
drugs, and devices. While there is a clear case for 
redistributing funds within the health sector from less 
to more effective forms of care, we should not be 
quick to assume that shrinking the sector would lead 
to more productive spending in other areas.
In a recent post on Technology, Academics, Policy 
(TAP) Blog, Pasquale refined the themes he discussed 
at the White House AI Now Conference and in his 
Duke article.  In the blog he discusses the pushback 
he got after the conference.  Even if complementary 
automation is better now, his critics asked “Shouldn’t 
our policy reward firms that try to eliminate ever more 
labor costs? Doesn’t everyone agree that the U.S. 
spends too much on health care—and isn’t technology 
the best way of reducing that spending?”  His blog 
post summarized his view that health economists 
need to offer a “positive industrial policy on where 
health spending should be going” rather than simply 
support austerity in health care spending without a 
foundational understanding of how spending should 
look.
Pasquale’s work goes beyond health care professions 
and focuses on automation in other professions as 
well, including the law.  Last year he published a 
short article in the UCLA Law Review Discourse 
titled “Four Futures of Legal Automation,” (63 
UCLA L. Rev. Disc. 28 (2015), co-authored with 
computer programmer Glyn Cashwell) that discusses 
how automation will affect the future of the legal 
profession.  In addition, Pasquale recently published 
two reviews of books that discuss the advance of 
automation: The Future of the Professions by Richard 
and Daniel Susskind in the L.A. Review of Books 
(March 15, 2016) and The Second Machine Age: 
Work, Progress, and Prosperity in a Time of Brilliant 
Technologies by Erik Brynjolfsson and Andrew 
McAfee’s in Boundary 2’s online edition (January 20, 
2015).
In addition to his scholarship on automation and 
the professions, Pasquale devotes time each week 
to examine broader developments in the field in 
his podcast, The Week in Health Law. Pasquale has 
produced nearly 70 episodes of the podcast with his 
co-host Professor Nicolas Terry. Recent topics of the 
podcast have included the Affordable Care Act and its 
impact on insurers, the ways health care is failing the 
obese, ransomware and its effect on the health care 
industry, drug pricing, and bioethics in reproductive 
technology development.  Recently, for Episode 
67, Pasquale and Terry had former L&HCP student 
Ameet Sarpatwari ’13 on the podcast.  Sarpatwari is 
now an instructor in medicine at Harvard Medical 
School and an associate epidemiologist with Brigham 
and Women’s Hospital. (See p. 5 for more about 
Sarpatwari.)  The podcast focused on the effects of 
laws and regulations on therapeutic drug development, 
approval, use, and related public health outcomes. The 
podcast is available on iTunes and Google Play Music.
Pasquale has also published several pieces addressing 
other issues in health law and policy over the past 
year. They include Reforming the Law of Reputation 
which addresses cutting edge challenges to health 
privacy caused by hacking and republication of 
breached medical records and Health Information 
Law, a chapter in The Oxford Handbook of American 
Health Law—which convened thought leaders in 
health law and policy to write about topics for which 
they are recognized experts. He is presently working 
on a piece exploring the privacy implications of 
corporate wellness programs.
5 │ Law & HeaLtH Care NewsLetter
The Law & Health Care Program at the University 
of Maryland Francis King Carey School of Law aims 
to prepare its students for any number of careers, and 
several recent graduates have gone on to distinguish 
themselves in the field of academia. 
Ameet Sarpatwari, PhD, JD, graduated from the 
School of Law with the Certificate in Health Law in 
2013. Upon graduation, he was awarded the Joseph 
Bernstein Award for the most significant student piece 
of scholarly writing in health law.  He now works as 
an instructor in medicine at Harvard Medical School 
and an associate epidemiologist with Brigham and 
Women’s Hospital. He also serves as assistant director 
for the Program On Regulation, Therapeutics, And 
Law (PORTAL) at the hospital and teaches public 
Law & Health Care Program Alums in Academia
health law at the Harvard T.H. Chan School of Public 
Health. 
Sarpatwari studies pharmaceutical policy issues 
such as the rising cost of prescription drugs and the 
U.S. Food and Drug Administration’s post-approval 
safety and effectiveness monitoring systems. A list of 
his recent publications are provided in the box below. 
Sarpatwari says he is currently working on developing 
ethical norms for the effective and equitable use of 
a particular safety program—risk evaluation and 
mitigation strategies (REMS) with elements to assure 
safe use—based on epidemiological investigations 
and focused interviews with patients, physicians, and 
regulators.
Ameet Sarpatwari: Selected Publications
•	 Kesselheim AS, Avorn J, Sarpatwari A. “The high cost 
of prescription drugs in the United States: origins and 
prospects for reform.” JAMA. 2016;316(8):858-71.
•	 Sarpatwari A, Avorn J, Kesselheim AS. “State 
initiatives to control medication costs—can 
transparency legislation help?” N Engl J Med. 
2016;374(24):2301-4.
•	 Sarpatwari A, Avorn J, Kesselheim AS. “Progress 
and hurdles for follow-on biologics.”  N Engl J Med. 
2015;372(25):2380-82.
•	 Sarpatwari A, Kesselheim AS. “The case for 
reforming drug naming: should brand name trademark 
protections expire upon generic entry.” PLoS Med. 
2016;13(2):e1001955.
•	 Kesselheim AS, Avorn J, Sarpatwari A. “The high cost of prescription drugs in the United States: 
origins and prospects for reform.” JAMA. 2016;316(8):858-71.
•	 Sarpatwari A, Choudhry NK, Avorn J, Kesselheim AS. “Paying physicians to prescribe generic drug 
and follow-on biologics in the United States.” PLoS Med. 2015;12(3):e1001802.
•	 Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS. “Practical, legal, and ethical issues in expanded 
access to investigational drugs.” N Engl J Med. 2015;372(3):279-86.
•	 Sarpatwari A, Franklin JM, Avorn J, Seeger JD, Landon JE, Kesselheim AS. “Are risk evaluation 
and mitigation strategies associated with less off-label use of medications? The case of ITP.” Clin 
Pharmacol Ther. 2015;97(2):186-93.
•	 Sarpatwari A, Kesselheim AS, Malin B, Gagne JJ, Schneeweiss S. “Ensuring patient privacy in data 
sharing for postapproval research.” N Engl J Med. 2014;371(17):1644-49.
•	 Sarpatwari A, Avorn J, Kesselheim AS. “Using a drug-safety tool to prevent competition.”  N Engl J 
Med. 2014;370(16):1476-78. 
•	 Sarpatwari A, Robertson CT, Yokum DV, Joiner K. “Crowdsourcing public health experiments: a 
response to Jonathan Darrow’s ‘Crowdsourcing Clinical Trials’.” Minn. Law Rev. 2014;98:101-20.
Ameet Sarpatwari ’13
Cont. on page 6
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Michael Ulrich ’11
When asked about how his law school experience 
is relevant to what he is doing now, Sarpatwari 
responded that “[t]he stellar faculty” at Maryland 
Carey Law helped to prepare him for his career. 
“Having the chance to learn from some dynamic 
scholars, particularly Richard Boldt, JD, and Rena 
Steinzor, JD, was invaluable. The one-on-one 
interaction, outside of class—you don’t get that 
elsewhere.”
Sarpatwari also valued his “field experience,” 
including an internship working with Marjorie Cook 
Professor of Law Karen Rothenberg, JD, MPA, on her 
bioethics research at the National Institutes of Health 
(NIH). He also worked with Ellen Weber, JD, in the 
Drug Policy Clinic that she founded at Maryland 
Carey Law, helping to draft and advocate for a 
Maryland law that increased access to naloxone, an 
opioid overdose antidote.
Maryland Carey Law’s L&HCP also helped launch 
another recent graduate into a career in academia.  
Since earning his law degree and the Certificate in 
Health Law in 2011, Michael Ulrich, JD, MPH, 
has worked at the University of Maryland Center for 
Health & Homeland Security, earned his master’s at 
the Harvard School of Public Health, worked at the 
National Institute of Allergy and Infectious Diseases’ 
Division of AIDS and just completed a two-year 
fellowship at Yale Law School working with Abbe 
Gluck, professor of law and faculty director of the 
Solomon Center for Health Law and Policy. In each 
of these positions, Ulrich managed to publish several 
articles. Writing, he says, is a passion. Evidence of this 
is the list of articles he has published since graduating. 
This fall Ulrich begins a new position as an assistant 
professor of health law, policy and management at the 
Boston University School of Public Health.
Michael Ulrich: Selected Publications
•	 Ulrich M. “Law and Politics, an Emerging Epidemic: A Call for 
Evidence-Based Public Health Law.” American Journal of Law & 
Medicine. 42 (2016): 256-283.
•	 Ulrich M (with others). “Lincoln’s Promise: Congress, Veterans, and 
Traumatic Brain Injury." Hastings Center Bioethics Forum (2016).
•	 Ulrich M. “Challenges for People With Disabilities Within the Health 
Care Safety Net.” 15 Yale Journal of Health Policy, Law, and Ethics 
247 (2015).
•	 Ulrich M. "The Impact of Law on the Right to Water and Adding 
Normative Change to the Global Agenda.” 48 George Washington 
International Law Review 43 (2015).
•	 Ulrich M. “Guidance From Vaccination Jurisprudence.” 13 American 
Journal of Bioethics 40 (2013).
•	 Ulrich M. “The Duty to Rescue in Genomic Research.” 13 American Journal of Bioethics 50 (2013).
•	 Ulrich M. “With Child, Without Rights?: Restoring a Pregnant Woman’s Right to Refuse Medical 
Treatment Through the HIV Lens.” 24 Yale Journal of Law and Feminism 303 (2012).
•	 Ulrich M. “Resource Restraints: Rethinking Disclosure of Individual Genomic Findings.” 128 
Michigan State University Journal of Medicine and Law 127 (2012).
•	 Ulrich M. “Researchers Without Borders?: Limiting Obligations of Ancillary Care Through the 
Rescue Model.” Vanderbilt Law School Health Law and Public Policy Forum (2011).
7 │ Law & HeaLtH Care NewsLetter
Ulrich said there is no question what inspired him 
to join academia—the faculty in the Law & Health 
Care Program at Maryland Carey Law. “What helped 
me the most was the open door policy that every 
professor had,” Ulrich said. “I loved the professors’ 
willingness to go above and beyond. With my papers, 
they would go through the issues with me, and 
suggest what to read, and go over my research. That’s 
really what drew me to the teaching part of academia. 
It was such a huge benefit and added so much to 
my learning experience. I wanted to provide that for 
students by teaching.”
Ulrich began his academic career speaking at the 
39th Annual Health Law Professors Conference held 
this year at Boston University (BU) School of Law. 
Ulrich’s talk was titled, “The Right to Bear Arms: 
A Pubic Health Law Approach.”  Ulrich will begin 
at BU by teaching a health law policy course this 
fall. He will also continue writing about gun rights 
and applying public health law doctrine to second 
amendment rights.  
Health Law Student Attends Seton Hall Law Healthcare 
Compliance Certification Program
Hillary Cleckler (3L) was awarded a 
scholarship to attend Seton Hall Law’s Healthcare 
Compliance Certification Program in June—the 
fourth Maryland Carey Law student to win the 
scholarship in the last several years.  Cleckler, 
who graduated from University of Michigan with 
an undergraduate degree in English, applied for 
the scholarship to learn more about a field into 
which she has already made significant inroads.  
Last Spring, Cleckler externed at the Office of 
Chief Counsel to the Inspector General of HHS 
doing health care fraud and abuse work.  After 
the compliance program in June, Cleckler spent 
the rest of the summer clerking at the inhouse 
counsel’s office at the University of Maryland 
Health Care System.
Cleckler was grateful for the opportunity to 
attend the compliance program saying “I learned 
so much while I was there, especially about laws 
I hadn't encountered thus far such as the FCPA 
and the Sunshine Act and got to meet people 
who have extensive experience in healthcare 
compliance.” In this final year of law school, 
Cleckler is busy as the President of the Student 
Health Law Organization and an editor on the 
Maryland Law Review.  Hillary Cleckler (3L) 
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Microbiome Transplantation Project Updates
In June 2015, Director of the L&HCP Diane 
Hoffmann was awarded an NIH grant to study 
the legal and regulatory aspects of a cutting edge 
medical treatment called microbiota transplantation. 
The most commonly known form of microbiota 
transplantation is the fecal microbiota transplantation 
(FMT) to treat C. Difficile infection, but the project 
is also looking at how to regulate other uses of FMT 
as well as other emerging microbiota transplantation 
options including vaginal, skin, anterior nares, oral, 
and whole body transplants.  See prior story about 
the grant in the Fall 2015 L&HCP newsletter.  The 
Working Group of stakeholders convened under the 
grant met for the first time on December 3-4, 2015 and 
for the second time on May 2-3, 2016.  The working 
group will meet for the last time on December 12-
13, 2016, at the Maryland Carey Law to discuss final 
recommendations to include in a project white paper.  
Project Updates
•	 On September 8, Hoffmann attended a one-day 
meeting of leading thinkers in microbiome-based 
research and in compassionate use hosted by 
Professor Arthur Caplan, founding Director of 
the Division of Medical Ethics at the New York 
University Langone Medical Center (NYULMC) 
and the founder of the NYULMC Working Group 
on Compassionate Use and Pre-Approval Access.  
The Compassionate Use Working Group studies 
issues relating to patients seeking access to 
therapies that have not received FDA approval but 
are in clinical trials.  Professor Caplan organized 
the FMT meeting because of the parallels between 
patient requests for compassionate use exceptions 
for unapproved drugs and patients seeking access 
to fecal-based treatments for indications for which 
there is no supporting efficacy and safety data.  
The goal of the meeting was to bring together 
experts whose experience would be helpful to 
those in the field who are thinking through how to 
respond to such requests from patients. 
•	 On May 31, Hoffmann and her co-investigators 
submitted formal comments to FDA on 
FDA’s “Draft Guidance for Industry (FDA-
2013-D-0811-0022): Enforcement Policy 
Regarding Investigational New Drug 
Requirements for Use of Fecal Microbiota 
for Transplantation to Treat Clostridium 
difficile Infection Not Responsive to Standard 
Therapies.” The comments informed FDA of 
the work of Hoffmann’s grant-funded working 
group to date, noting that the comments 
to FDA were premised on the concept that 
“regulating FMT requires a framework that 
balances patient safety with the need to provide 
appropriate access to the procedure and one 
that does not unduly discourage research on the 
effectiveness of microbiota transplantations.”  
The co-investigators also commented on FDA’s 
regulation of FMT to date, specific aspects of the 
draft guidance including whether the traditional 
Investigational New Drug (IND) process is 
wholly appropriate for FMT, and whether 
certain IND requirements should be modified or 
waived for microbiota transplantation.  
•	 Hoffmann and her co-investigators have 
submitted an article for publication in a 
forthcoming issue of the journal of Gut Microbes 
titled “Commentary: A Proposed Definition 
of Microbiota Transplantation for regulatory 
purposes.” The commentary fills a vacuum 
in the regulatory discussion of microbiota 
transplantation which has proceeded to date 
without an accepted definition of microbiota 
transplantation from FDA or any other source.  
The commentary sets forth a definition based on 
working group discussion and co-investigator 
research.  The article also highlights the critical 
need for a definition to guide how microbiota 
transplantation should be regulated because the 
definition of a product or process is often pivotal 
in determining which FDA regulatory pathway 
the product or process will traverse.
The other co-investigators on this project are Dr. 
Frank Palumbo, Center on Drugs and Public Policy, 
University of Maryland School of Pharmacy, Dr. 
Jacques Ravel, Institute for Genome Sciences, 
University of Maryland School of Medicine, 
Dr. Mary-Claire Roghmann, Department of 
Epidemiology and Public Health, University 
of Maryland School of Medicine, Dr. Erik von 
Rosenvinge, Division of Gastroenterology, University 
of Maryland School of Medicine and Veterans 
Affairs Maryland Health Care System and Virginia 
Rowthorn, Law & Health Care Program, University 
of Maryland Carey School of Law.
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Local Health Care Organizations Create  
New Business Fellowships
When the call went out to identify businesses to 
engage in Maryland Carey Law’s new Business 
Fellowship Program, local health care organizations 
and alumni of the Law & Health Care Program were 
among the first to respond.  The program places 
law students and recent graduates in Baltimore-
area businesses to help Maryland companies and 
institutions meet their business and legal needs 
while providing growth opportunities for the next 
generation of law and business leaders.  The program 
supports 10-week Summer Fellowships and year-
long Postgraduate Fellowships.  The University of 
Maryland Medical System (UMMS), FutureCare, 
LifeBridge Health, Evergreen Health, and Vasoptic 
Medical Inc. were among the inaugural fellowship 
partners offering paid placements to students.  The 
program’s postgraduate business fellowships are open 
to new Maryland Carey Law alumni who work for 12 
months working in the  legal and business departments 
of the organizations.  According to Maryland Carey 
Law's Office of Career Development, after the first 
year of the program, employer organizations reported 
that they were extremely impressed with the work of 
their fellows and the law school received extremely 
positive feedback from the selected students.
Jaclyn Machometa ’15 spent her first year out of law 
school as a fellow in the Office of General Counsel 
at UMMS where she gained invaluable legal drafting 
experience in various health law matters including 
physician contracting, corporate transactions, 
corporate creation/structuring, guardianships, and 
affiliation and vendor agreements.  She said of the 
Fellowship Program, “It was the perfect opportunity 
for me to gain hands on experience in the fields of 
both health and business law, two areas in which I 
hope to establish a successful law career.”  Vince 
Andrews, a 2016 graduate of the Law & Health Care 
Program, is the organization’s current fellow.
Reena Palanival (3L) spent her summer as a 
fellow at Vasoptic Medical Inc., a company that  
is developing a low-cost, easy-to-use, portable 
retinal imager designed to non-invasively capture 
physiological information from the retina.  This 
approach eliminates the need for pupil dilation or 
contrast dyes and allows for important eye exams to 
be performed in primary care and community care 
Evergreen Health Co-op
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environments to increase access to eye exams for 
at-risk and underserved populations.  Vasoptic was 
started by L&HCP alum M. Jason Brooke (see Fall 
2015 L&HCP newsletter) who rose to the challenge 
of creating a Fellowship opportunity to provide 
hands-on legal and business expertise to students.  
At her placement, Palanivel analyzed agreements 
for consistency and critical provisions relevant to 
the business operations, reviewed and summarized 
patent related prior art, researched and analyzed 
reimbursement policies related to retinal imaging, and 
drafted standard operating procedures for compliance 
with FDA regulations.  She said of her time in the 
Fellowship that it was not only invaluable in providing 
her with experience in the interplay between health 
and business, but also professionally enriching, 
providing her with lifelong mentors. 
L&HCP graduate Maryann Hong ’16 is currently a 
postgraduate fellow at Evergreen Health, Maryland’s 
only Health Care Cooperative, a member-driven 
company created under the Affordable Care Act as 
an innovative way to provide health insurance.  One 
of Evergreen Health’s attorneys is L&HCP alum, 
Elliott Hooper ’13, who was instrumental in bringing 
Evergreen to the Business Fellowship Program.  Of 
the Program, Hooper says the opportunity to partner 
with Maryland Carey Law and the L&HCP was 
particularly enticing to Evergreen Health. Evergreen 
Health was drawn to the Fellowship Program by the 
academic strength of Maryland Carey Law students 
and the well-versed background in health law students 
receive from the L&HCP. Evergreen Health felt the 
academic strength of the L&HCP would prepare 
fellows to actively contribute in a meaningful way 
from the outset of their fellowship.
Several Law & Health Care Program faculty members spoke at the 39th Annual Health Law Professors 
Conference in June.  The conference was co-sponsored by the American Society of Law, Medicine & 
Ethics, Boston University School of Law, and Boston University School of Public Health.
Preeti Emrick, University of Maryland Center for Health and Homeland Security and University of 
Maryland Law School, U.S. Public Health Law: Archaic or Relevant in the Context of Ebola?
Diane Hoffmann, University of Maryland Law School, Microbiota-Related Therapies and the Challenges 
They Create for FDA 
Leslie Meltzer Henry, University of Maryland Law School, Conducting Research with Pregnant Women: 
Ethical and Legal Challenges in the Zika Pandemic 
Frank Pasquale, University of Maryland Law School, Data Acquisition and Consent in Learning Health 
Care Systems 
Maryland Carey Law Faculty Speak at Annual Health Law 
Professors Meeting
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Professor Kathleen Hoke Brings Together Public Health 
Stakeholders Around Complex Health Issues
As part of its mission to provide pro bono technical 
legal assistance on a wide range of public health 
issues, the Legal Resource Center for Public Health 
Policy (LRC) at the University of Maryland Francis 
King Carey School of Law is continually searching for 
ways to reach a broader variety of stakeholders.
In June, the LRC co-hosted the Maryland Healthy 
Housing Symposium at Turf Valley Resort and 
Conference Center in suburban Baltimore. LRC 
Director and Law School Professor Kathleen Hoke, JD 
’92, greeted approximately 100 federal, state, and local 
health and housing officials at the symposium, which 
focused on challenges faced by vulnerable populations 
who live in substandard housing, increasing their 
susceptibility to related illness and injury. 
The symposium topics included: the link between 
housing and health; the environmental exposures 
that affect individuals in the home (e.g. lead, radon, 
mold, etc.); the impact smoking has on individuals 
living in multi-unit housing; and the U.S. Department 
of Housing and Urban Development’s (HUD) 
proposed rule to prohibit smoking in public housing— 
specifically, what it would mean for public housing 
authorities and residents in Maryland.
Hoke noted that “since its inception in 2001, the 
LRC has worked to assist state and local public health 
officials to address the devastating impact of exposure 
to secondhand smoke, with a particular focus on 
vulnerable populations, such as youth, senior citizens, 
and those with chronic illnesses.” 
The LRC assisted with gaining passage of the 
2007 Maryland Clean Indoor Air Act and related 
regulations, securing protections for hospitality 
workers who had been carved out of protections when 
other workplaces were rendered smoke-free in 1992. 
“Seeking these same protections for those exposed in 
public housing was a natural extension of these earlier 
efforts,” Hoke said.
In addition to attracting public housing authorities, 
property managers and owners, local health 
departments and coalitions, and faith- and community-
based organizations from across Maryland and the 
District of Columbia, the symposium also featured a 
wide range of health and housing experts as speakers.
Peter Ashley, DrPH, HUD’s director of Healthy 
Homes and Lead Hazard Control, discussed the 
agency’s role in overseeing public housing authorities 
and federally subsidized properties, and promoting 
healthier homes programs nationwide. He highlighted 
economic, health, and safety reasons for HUD 
proposing a rule that would require all public housing 
authorities to prohibit smoking in individual units, 
common areas, and within 25 feet of buildings.
“Secondhand smoke has a lot of toxic and 
carcinogenic chemicals, and it doesn’t stay only in the 
unit of the smoker in a multi-family property,” Ashley 
said. “Also, tobacco smoking is an important safety 
issue in that it is the major cause of fatal residential 
fires.”
Cliff Mitchell, MS, MD, MPH, director of the 
Environmental Health Bureau for the Maryland 
Department of Health and Mental Hygiene (DHMH), 
which co-sponsored the symposium with Maryland 
Carey Law, spoke about the link between housing 
and emotional, mental, and physical health; the 
importance of providing healthy and safe living 
spaces, particularly for vulnerable populations, such 
as children; and the prominent role that communities 
play in ensuring access to healthy and safe housing.
Professor Kathleen Hoke
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Other speakers included LRC deputy director and 
symposium organizer William Tilburg, JD ’11; Dana 
Moncrief, MHS, CHES, chief, Statewide Public 
Health Initiatives, DHMH; Tiffany Smith, MHSA, 
from Howard County Housing; Tiffany Nicolette 
from Shelter Properties, LLC; Laura Hale from the 
American Lung Association; and Bob Vollinger, 
MSPH, program director, Tobacco Control Research 
Branch, National Institutes of Health.
“The speakers brought many different perspectives 
to the discussion of ethical and effective methods 
of assuring healthy housing for the least among us,” 
said Hoke, who opened and closed the five-hour 
symposium. “Simply gathering an eclectic group of 
health and housing officials, offering various voices 
and perspectives during the symposium, and allowing 
for vigorous discussion created an environment rich 
for further collaboration and cooperation. This cross-
cutting effort should result in comprehensive policy 
options to reduce not only exposure to secondhand 
smoke but also to other environmental hazards, such 
as radon and mold.” 
In addition to tobacco regulation and environmental 
health, the LRC has been examining the public 
health consequences of electronics; the medical use 
of marijuana; and regulation of gambling hotline 
ads. Hoke sees the Center playing an even greater 
innovative role in the future.
“In collaboration with the Department of Health 
and Mental Hygiene and Maryland’s 24 local health 
departments, we are working to develop sound, 
evidence-based policy options appropriate for state 
and local governments and for public and private 
housing. The Maryland Healthy Housing Symposium 
took us another step along that path.”
William Tilburg
Meet Will Tilburg, the Legal Resource Center’s 
Deputy Director
Will Tilburg is the Deputy Director of the Legal Resource 
Center for Public Health Policy and Senior Staff Attorney 
with the Network for Public Health Law, Eastern Region, 
both of which are located at Maryland Carey Law.  Tilburg 
graduated with honors from the law school in 2011 and 
started working in both his current roles shortly after 
graduation.  He assists the Director of both programs, 
Professor Kathleen Hoke, in their work with state and local 
legislators, government attorneys, and health officials on 
legal and policy issues related to public health.  Tilburg 
is also an adjunct professor at Maryland Carey Law and 
University of Maryland School of Public Health, where he 
teaches courses on health law and ethics, environmental 
law, and oral advocacy.  His focus areas include housing, 
environmental health, medical marijuana, nutrition and 
physical activity, and tobacco control.  In June 2016, 
Tilburg organized the Maryland Healthy Housing 
Symposium mentioned in the prior article that brought 
together 100 stakeholders to focus on challenges faced by 
individuals living in substandard housing.  In September, 
he organized and moderated a panel at the National 
Public Health Law Conference in Washington, DC called 
“Efficient, Health and Safe Housing.”  The session 
examined innovative state and local policy interventions to 
improve the housing situation of vulnerable populations.
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Law & Health Care Program Graduates 38 Students
At a gala celebration in May, Dean Donald Tobin, 
L&HCP Director Diane Hoffmann, and L&HCP 
faculty celebrated the success of health law certificate 
students with their friends and family.  The celebration 
marked the 19th year of the certificate program.  The 
students were individually recognized by the faculty 
who delivered personal comments about each of the 
graduates before they got their certificate.
All of the program’s certificate students followed 
different pathways determined by their particular 
interest within health law.  Some focused on mental 
health issues, others on business aspects of the health 
care industry and still others on public health law.  
Below we share the pathways of several of our 2016 
grads.
Vincent Andrews
Vincent graduated from Cornell University with 
an undergraduate degree in Industrial and Labor 
Relations in 2011 before coming to Maryland.  While 
in law school, Vincent externed at Care First Blue 
Cross Blue Shield in their Office of General Counsel 
where he worked on a wide range of issues including 
a subscriber appeal before an Administrative Law 
Judge and matters before the Maryland Insurance 
Administration.  His supervisor, Meredith Borden, 
found him to be incredibly enthusiastic and eager 
to learn about the business side of the health care 
industry.  Vincent wrote his Advanced Writing 
Requirement Paper on the relationship between state 
spending on mental health services for minors and 
rates of juvenile incarceration. The paper looked at 
how states interpreted and implemented SCHIP and 
IDEA, which in turn affected state spending on mental 
health services.  Professor Diane Hoffmann, who was 
his faculty advisor, said of the paper, “[i]t went far 
beyond what I expected. While his legal research and 
analysis were excellent and thorough, Vincent also 
taught himself how to do multiple regression analysis 
—no easy task!”   His enthusiasm and this experience 
led to his selection as this year’s Business Fellow 
at the University of Maryland Medical System’s in 
house counsel’s office.   In this position, he assists 
on a wide range of activities, from drafting physician 
2016 Health Law Certificate Graduates and L&HCP Faculty
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incredibly well trained, but she is also optimistic, 
kind and empathic in a way that is impossible not 
to notice.”  As Boldt’s research assistant, Samantha 
helped with a project examining the outpatient 
commitment of individuals with serious mental illness, 
which resulted in the development of an article that 
was published in the New England Law Review.  
According to Boldt, “her investigation of state 
statutes, funding mechanisms, and judicial opinions 
in the area was detailed, thorough, and absolutely 
essential to the overall project.”  In addition, Samantha 
served on the Executive Board of the Student Health 
Law Organization, as managing editor of the Journal 
of Health Care Law and Policy, and also competed 
in both the Loyola Chicago National Health Law 
Transactional Competition and the Maryland Health 
Law Regulatory & Compliance Competition.  
Samantha came to the law school with a public health 
degree which helped her shine in Professor Weber’s 
Drug Policy Clinic.  Professor Weber reported that 
her work on developing and drafting the Clinic’s 
comments to proposed State regulations on the 
certification of substance use treatment services 
and their integration with mental health services 
demonstrated the sort of methodical and thorough 
research and analysis that few students could have 
performed.  Samantha is putting her health law and 
policy degree to use as regulatory counsel at the 
Center for Tobacco Control at FDA.
employment contracts and lease arrangements to 
analyzing patient care and Stark/anti-kickback issues.  
An article about the Business Fellowship appears on 
page 9 of this newsletter.
2016 Graduates Kelsey Harrer, Alexandria Montanio and 
Samantha Collado (from l to r )
L&HCP Director Diane Hoffmann, 2016 Graduate Allison 
Kronback and Prof. Ellen Weber (from l to r)
Monica Basche  
Like many health law students who come to 
Maryland Carey Law, Monica had health-related 
experience in her background.  As a Legal Marketing 
Manager for Agora, a publishing and information 
services company, she worked primarily with 
clients in the dietary supplement industry, editing 
their marketing materials and newsletters.  At the 
law school, Monica served as an executive articles 
editor for the Maryland Law Review and research 
assistant for Professor Donald Gifford in addition to 
participating in a number of organizations, externing 
at the Maryland Office of the Attorney General and 
Food and Drug Administration, and engaging in 
community service.  Monica has chosen to pursue the 
judicial clerkship route to prepare her for her career.  
This year she will be clerking with Judge Adkins at the 
Maryland Court of Appeals and in August 2017, will 
start a two-year clerkship with Judge George Russell 
at the U.S. District Court for the District of Maryland.  
Describing her experience at the law school, Monica 
said, “Maryland's Law and Health Care Program was 
one of the most important parts of my law school 
experience because it showed me how health law 
intersects with so many different practice areas and 
gave me access to externship opportunities that I 
wouldn't have had anywhere else.”
Samantha Michelle Loh Collado  
According to her mentor, L&HCP Professor 
Richard Boldt, Samantha stood out as a law student 
for multiple reasons—“she is serious, smart, and 
Alexandria Montanio 
Alex graduated from University of Virginia in 2011 
with High Distinction in Psychology and Distinction 
in English.  At the law school, she was equally as 
distinguished.  Alex was 11th in her class, a Leadership 
Scholar, co-president of the winning Alternative 
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Dispute Resolution Team and staff editor of the 
Journal of Health Care Law and Policy.  She also 
externed at the Maryland Disability Law Center (now 
Disability Rights Maryland) where she performed 
site visits to programs to check for abuse and neglect 
of vulnerable clients.  Perhaps her most prominent 
achievement in law school was being part of the 
team that won the 5th Annual Health Law Regulatory 
and Compliance Competition held at the law school.  
This is the L&HCP’s own competition but, during 
the first four years of the event, the Maryland team 
never placed.  In 2016 with Alex and two fellow 
students, Maryland Carey Law brought home the big 
plaque.  Professor Frank Pasquale, faculty mentor 
to the competition, said of Alex, “she is a brilliant 
writer and thinker, also blessed with a great sense of 
humor and perspective. She brought extraordinary 
real-world experience to both my health law and 
administrative law classes, and capped her career 
here with a contribution to the emerging field of 
algorithmic accountability. She uncovered problems in 
organ allocation I was unaware of, and has developed 
a clear regulatory proposal to address discrimination 
against the disabled in that context.”  Alex clerked at 
Evergreen Health (Maryland’s only Health Care Co-op 
created under the ACA and described on p. 9).  She is 
putting all this experience to work at Gordon Feinblatt 
in their litigation and health care practices as a first 
year associate.
Theresa Thompson   
It’s hard to exaggerate Theresa’s commitment to 
the Law & Health Care Program during her three 
years at Maryland.  She was the President of the 
Student Health Law Organization (SHLO) for two 
years, during which time the organization supported a 
number of new and highly successful educational and 
networking events.  In particular, Theresa spearheaded 
the Health Law Networking and Resume Review 
Reception during which health law practitioners 
review student resumes in advance and go over them 
with students at a reception which also includes an 
element of “speed networking.”  In addition to her 
activities with SHLO, Theresa was on the team with 
Alex Montanio that won the Maryland Carey Law 
Health Law Regulatory and Compliance Competition.  
She also participated in the Loyola Chicago National 
Health Law Transactional Competition.  Finally, 
she was manuscripts editor of the Journal of Health 
Care Law & Policy, treasurer of the Women's Bar 
Association, and a UMB President's Entrepreneurial 
Fellow.  She is now a first-year associate at Epstein 
Becker Green in Washington and has promised to stay 
involved as an alum for years to come. 
L&HCP Director Diane Hoffmann, 2016 Graduate Michael 
Vinluan and Prof. Richard Boldt (from l to r)
Michael Vinluan  
Michael came to the law school with a medical 
degree under his belt and prior to law school had 
worked with the CDC, consulting with clinicians and 
health departments across the United States on issues 
including critical health threats, disease outbreaks, 
and bioterrorism.  His experience as a physician gave 
Michael a unique and valuable perspective on the 
topics raised in his health law courses—something 
appreciated by his professors and fellow students.  
Another way in which his medical background 
privileged Michael was in the realm of externships.  
He was able to secure multiple placements at 
FDA. These externships led to a one-year Fellowship 
in the FDA’s Office of the Commissioner. He also 
served as a law clerk at Johns Hopkins Hospital in 
their in-house counsel’s office.  When each placement 
ended, his supervisors asked him to stay on but 
Michael was committed to finishing law school.  
During law school, Michael worked as a consulting 
medical expert for litigation law firms. He currently 
works as a medical-legal consultant for law firms in 
Washington, D.C. and Baltimore. According to his 
mentor, Professor Richard Boldt, “Michael is just the 
sort of person who makes our Law and Health Care 
Program so fabulous. I expect to hear great things 
about his work in the years to come, and I feel lucky 
to have had the opportunity to be a part of his legal 
education.”







































2016 health law certificate recipients 
 
Third Annual Interprofessional Forum on Ethics and Religion in Health Care
CHALLENGES IN ORGAN DONATION & 
TRANSPLANTATION
Tuesday, November 1, 2016
UMB’s Southern Management Corporation  
Campus Center 
621 W. Lombard St., Baltimore, MD
Presented by the University of Maryland Schools of Medicine, Nursing, Pharmacy, and 
Social Work; the UMB Graduate School; the Maryland Healthcare Ethics Committee 
Network at Maryland Carey Law; and the Institute for Jewish Continuity 
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of the Law & Health 
Care Program at 
Maryland Carey 
Law, was asked by 
the president of the 
Federation of State 
Medical Boards if 
she would serve 
on the Composite 
Committee for the 
United States Medical Licensing Exam (USMLE). 
The USLME is the single pathway for licensure for all 
medical school graduates (from schools in the U.S. as 
well as other nations) who wish to practice allopathic 
medicine in the U.S.  The exam provides state 
medical boards with information they need about the 
competency of applicants for licensure in their state. 
The Composite Committee is the governing board for 
the USMLE program. It is “responsible for the overall 
direction of the program identifying and approving 
procedures for scoring and determining the pass/fail 
standard, and all significant policies and procedures.”1 
The committee is composed of representatives from 
the Federation of State Medical Boards (FSMB), 
the National Board of Medical Examiners (NBME), 
the Educational Commission for Foreign Medical 
Graduates (ECFMG) and the public. The FSMB, a 
non-profit organization, represents the 70 medical 
and osteopathic boards of the United States and its 
Territories. The NBME, also a non-profit organization, 
prepares exams and assessments for a number of 
health professional groups and the ECFMG certifies 
international medical graduates desiring to enter U.S. 
graduate medical education.
All physicians who successfully completed medical 
school and residency and became licensed to practice 
medicine in the U.S. since the early 1990s have 
taken the USMLE.  The exam replaced the NBME 
Part Examination Program and the Federation 
Licensing Exam (FLEX). The exam includes three 
standardized assessments called step exams. The 
first step is typically taken by medical students after 
their second year of medical school. It focuses on the 
basic sciences and tests whether students understand 
and are able to apply scientific principles that form 
the foundation for the safe and competent practice of 
medicine. Step 1 scores are often used by residency 
programs in selecting graduating medical students. 
Failure on Step 1 may prevent a student from moving 
forward in the medical school curriculum from the 
basic sciences to the clinical sciences curriculum.
Step 2 is divided into two parts, Clinical Knowledge 
and Clinical Skills. Students must pass both parts in 
order to receive their medical degree and to be granted 
a temporary state license to practice during their first 
year of residency training. Step 2 evaluates whether 
a medical student or graduate can apply medical 
knowledge, skills and understanding of clinical 
science essential for providing medical care under 
supervision. The first part of the exam is given as a 
traditional exam; the second part, Clinical Skills, uses 
standardized patients and focuses on a candidate’s 
communication and problem-solving skills. 
Step 3 is typically taken after the first year of 
medical residency and in all states passage of step 3 is 
required for permanent licensure. It assesses whether 
applicants “can apply medical knowledge and their 
understanding of biomedical and clinical science 
essential for the unsupervised practice of medicine, 
with emphasis on patient management in ambulatory 
settings.”2 
Hoffmann attended her first meeting of the 
Composite Committee in June in Philadelphia and was 
impressed by the dedication and commitment of its 
members to ensure that the exam process is one that 
well prepares individuals to practice medicine and 
assures the public that their doctors have achieved a 
minimum level of competency.
______________________
1 Who is USMLE? At www.usmle.org/about/ 
2 Federation of State Medical Boards and National Board 
of Medical Examiners. United States Medical Licensing 
Examination: Step 3 at www.usmle.org/step-3/
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The Affordable Care Act: Too Big to Fail?
October 20, 2016, 5:30-7:00 pm
University of Maryland Carey School of Law
Ceremonial Moot Court Room, First Floor
Open to Public, Reception to Follow
As the 2016 Presidential election nears, candidates on different sides of the aisle have very different views 
of the future of the Affordable Care Act (ACA).  Hillary Clinton wants to “defend and expand” the ACA and 
make a “public” insurance option available to consumers.  Donald Trump asserts that “on day one of the 
Trump Administration, we will ask Congress to immediately deliver a full repeal of Obamacare.”  Members 
of Congress are equally split on the law’s future.
It has been over five years since the law was enacted.  Who have been the winners and who have been 
the losers under the most ambitious overhaul of the nation’s health care system since Medicare was created 
in 1965?  What is the future of the law if Clinton wins or if Trump wins?  Is it too big to fail?  Which 
components of the ACA are at most risk with either candidate?  This election panel will look back at the 
history of the ACA but, more importantly, look forward to the program’s future with representatives from 
government agencies, insurance agencies and consumer representatives.
Panelists
Leonardo Cuello, JD, Director, Health Policy, NHeLP
Elizabeth Milito, JD, Senior Executive Counsel at National Federation of Independent Business
Kimberly Robinson, JD, Partner, Funk & Bolton and Executive Director of the League of Life and Health
Insurers of Maryland
Beth Sammis, Adjunct Lecturer, Anne Arundel Community College and Board Member, Consumer Health
First (former Acting Insurance Commission for the State of Maryland)
Moderator
Diane E. Hoffmann, JD, MS, Professor of Law, Director, Law & Health Care Program University of
Maryland Carey School of Law
Sponsored by the Karen Rothenberg and Jeffrey Seltzer Law & Health Care Program Fund 
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SAVE THE DATE
Zika Global to Local: Addressing the Epidemic from an 
International and Interprofessional Lens
As the Zika virus moves deeper into North America, 
different sectors of U.S. society are mobilizing to 
address the epidemic by preventing the spread of 
the virus, identifying patients, treating affected 
individuals, and working toward a vaccine.  Faculty 
members at University of Maryland, Baltimore 
(UMB) are on the front line of the fight against Zika 
using their expertise to develop and refine the legal, 
medical and regulatory tools needed to face a new 
epidemic.  How Zika is addressed in the U.S. and our 
own community in Baltimore will be greatly informed 
by the experience of countries in South and Central 
America where the virus first emerged. 
The Law & Health Care Program and the Center 
for Global Education Initiatives is hosting a panel 
on February 15, 2017 to learn about the Zika virus 
from UMB faculty on the front lines of Zika research 
as well as from the Costa Rican Ambassador to the 
U.S. who brings his perspective as both a government 
official in an affected country and a biotechnologist.  
Join us at this informative public discussion.
Panelists
Dr. Roman Macaya, ambassador of Costa Rica to the 
U.S. Ambassador Macaya has a 
multidisciplinary background as a scientist, 
businessman, advocate, politician, and academic.  As 
a chemist and biochemist by training, Ambassador 
Macaya has led R&D teams in the fields of 
biotechnology and biomedical research.  The 
Ambassador has authored numerous articles in 
peer-reviewed journals in the life sciences and was 
lead inventor on a patent application for a drug 
candidate.  As an Ambassador, Dr. Macaya has given 
Science Diplomacy a high priority, an effort that has 
yielded concrete results in science and technology 
collaborations between the United States and Costa 
Rica. 
Professor Michael Greenberger, professor at 
Maryland Carey Law and director of the University of 
Maryland Center for Health and Homeland Security 
(CHHS).  Professor Greenberger and CHHS are 
actively working with governmental clients to develop 
plans on how to respond to emerging infectious 
diseases, including Zika.
Professor Leslie Meltzer Henry, professor at 
Maryland Carey Law.  Professor Henry and colleagues 
at other institutions were recently funded by the 
Wellcome Trust to develop ethical and legal guidance 
for conducting research with pregnant women during 
public health emergencies, like the Zika crisis, where 
there is an urgent need to attend to the health needs 
of pregnant women and their offspring.  The project 
is called “Conducting Ethical Research with Pregnant 
Women in the Emerging Zika Pandemic and Beyond: 
Challenges Arising in Public Health Crises.”
Dr. Jon Mark Hirshon, professor in the Department 
of Emergency Medicine and in the Department of 
Epidemiology and Public Health at the University 
of Maryland School of Medicine. He is the former 
director of the Charles McC. Mathias, Jr. National 
Study Center for Trauma and EMS and is currently the 
senior vice-chairman of the University of Maryland, 
Baltimore's IRB. Dr. Hirshon recently published 
“Zika Virus: Critical Information for Emergency 
Providers” with colleagues and, as a board member 
of the American College of Emergency Physicians, is 
working on the organization’s guidelines for the virus.
Dr. Kathleen Neuzil, director, Center for Vaccine 
Development at University of Maryland School of 
Medicine.  The Center for Vaccine Development has 
been chosen as one of three study sites in a human 
safety trial of a new Zika vaccine. The early-stage 
study will evaluate the experimental vaccine’s safety 
and ability to generate an immune system response in 
participants.
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Law & HeaLtH Care Program
500 West Baltimore Street
Baltimore, MD 21201
www.law.umaryland.edu/healthlaw
Comments and letters should be 
forwarded to the above address.
Support the Law & Health Care Program
The Law & Health Care Program has hosted a number of hallmark meetings and roundtables to bring 
together health care practitioners, legal academics, medical experts, scientists, and policymakers to 
examine cutting-edge issues in health policy, law, or ethics. Over the next 30 years, we hope to count you 
as a partner in this effort. We plan to build on the stellar foundation we have created as health law educators 
to keep asking questions and pushing the field of health law forward. In order to do this, we are asking for 
your support. Every contribution helps our program achieve its goals.
There are two ways to give to the Law & Health Care Program:
~ Online at http://www.law.umaryland.edu/give/healthlaw 
~ Mail, by sending a check made payable to: UMBF, Inc./ Law & Health Care 
to 620 West Lexington Street, 2nd Floor, Baltimore, MD 21201
Funds for the Law & Health Care Program are administered by the University of Maryland, Baltimore Foundation, Inc.
